Amoxycillin + Clavulanic Acid in pharma franchise in Assam

Amoxycillin + Clavulanic Acid in PCD pharma franchise in Dehradun

Amoxycillin + Clavulanic Acid in top pharma company in Bhopal

Amoxycillin + Clavulanic Acid In pcd pharma supplier in Navi Mumbai

Amoxycillin + Clavulanic Acid in phama franchise company in India
Amoxycillin + Clavulanic Acid in phama distributor in Meerut

Home/Products /amoxycillin-500mg-clavulanic-acid-100mg-injection

Moxyplit CV 600 Injection

Composition : Amoxycillin (500mg) + Clavulanic Acid (100mg)

Dosage Form : Injection

Packaging Type : vial+water

Packaging : mono

Price : ₹105/-

Moxyplit CV 600 Injection is a highly effective antibiotic combination consisting of Amoxycillin and Clavulanic Acid. Amoxycillin is a broad-spectrum antibiotic that targets the bacterial cell wall, causing cell death in susceptible bacteria. Clavulanic Acid is a beta-lactamase inhibitor that prevents certain bacteria from breaking down Amoxycillin, allowing the antibiotic to remain effective against resistant strains. This combination therapy enhances the treatment of various bacterial infections, particularly those caused by beta-lactamase-producing microorganisms.

Moxyplit CV 600 Injection is indicated for the treatment of moderate to severe bacterial infections, especially those that require intravenous antibiotic therapy. It is commonly used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, as well as intra-abdominal infections. The combination of Amoxycillin and Clavulanic Acid is essential for effectively treating infections caused by resistant organisms, providing a broader spectrum of activity.

Read More

About the Product

Moxyplit CV 600 Injection is a highly effective antibiotic combination consisting of Amoxycillin and Clavulanic Acid. Amoxycillin is a broad-spectrum antibiotic that targets the bacterial cell wall, causing cell death in susceptible bacteria. Clavulanic Acid is a beta-lactamase inhibitor that prevents certain bacteria from breaking down Amoxycillin, allowing the antibiotic to remain effective against resistant strains. This combination therapy enhances the treatment of various bacterial infections, particularly those caused by beta-lactamase-producing microorganisms.

Moxyplit CV 600 Injection is indicated for the treatment of moderate to severe bacterial infections, especially those that require intravenous antibiotic therapy. It is commonly used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, as well as intra-abdominal infections. The combination of Amoxycillin and Clavulanic Acid is essential for effectively treating infections caused by resistant organisms, providing a broader spectrum of activity.

Possible side effects of this medication include nausea, vomiting, diarrhea, and oral thrush.

Moxyplit CV 600 Injection is prescribed to treat bacterial infections in the lungs, sinuses, urinary tract, skin, and soft tissues.

Information regarding the use of Moxyplit CV 600 Injection during breastfeeding is not available. Please consult your doctor.

Store in a cool, dry place. Protect from light. Reconstituted solutions should be used promptly and stored according to specific instructions provided.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation